Rotily M, Bentz L, Pradier C, Obadia Y, Cavailler P. Factors related to delayed diagnosis of HIV infection in southeastern France. Int J STD AIDS. 2000;11(8):531–5.
Article
CAS
Google Scholar
Lin K-Y, Cheng C-Y, Li C-W, Yang C-J, Tsai M-S, Liu C-E, et al. Trends and outcomes of late initiation of combination antiretroviral therapy driven by late presentation among HIV-positive Taiwanese patients in the era of treatment scale-up. PLoS One. 2017;12(6):e0179870.
Article
Google Scholar
Mocroft A, Lundgren JD, Sabin ML, Monforte AA, Brockmeyer N, Casabona J, et al. Risk factors and outcomes for late presentation for HIV-positive persons in Europe: results from the collaboration of observational HIV epidemiological research Europe study (COHERE). PLoS Med. 2013;10(9):e1001510.
Article
Google Scholar
Valdiserri RO. Late HIV diagnosis: bad medicine and worse public health. PLoS Med. 2007;4(6):e200.
Article
Google Scholar
Camoni L, Raimondo M, Regine V, Salfa M, Suligoi B, Regional representatives of the HIV Surveillance System. Late presenters among persons with a new HIV diagnosis in Italy, 2010–2011. BMC Public Health. 2013;13:281.
Likatavicius G, Van de Laar M. HIV and AIDS in the European Union, 2011. Eurosurveillance. 2012;17(48):20329.
Article
Google Scholar
Buetikofer S. Prevalence and risk factors of late presentation for HIV diagnosis and care in a tertiary referral Centre in Switzerland: (Doctoral dissertation, University of Zurich); 2014.
Celesia B, Castronuovo D, Pinzone M, Bellissimo F, Mughini M, Lupo G, et al. Late presentation of HIV infection: predictors of delayed diagnosis and survival in eastern Sicily. Eur Rev Med Pharmacol Sci. 2013;17(16):2218–24.
CAS
PubMed
Google Scholar
Des Jarlais DC, Friedman SR, Choopanya K, Vanichseni S, Ward TP. International epidemiology of HIV and AIDS among injecting drug users. Aids. 1992;6(10):1053–68.
Article
CAS
Google Scholar
Suárez-García I, Sobrino-Vegas P, Dalmau D, Rubio R, Iribarren JA, Blanco JR, et al. Clinical outcomes of patients infected with HIV through use of injected drugs compared to patients infected through sexual transmission: late presentation, delayed anti-retroviral treatment and higher mortality. Addiction. 2016;111(7):1235–45.
Article
Google Scholar
Celentano DD, Galai N, Sethi AK, Shah NG, Strathdee SA, Vlahov D, et al. Time to initiating highly active antiretroviral therapy among HIV-infected injection drug users. Aids. 2001;15(13):1707–15.
Article
CAS
Google Scholar
Gebo KA, Fleishman JA, Conviser R, Reilly ED, Korthuis PT, Moore RD, et al. Racial and gender disparities in receipt of highly active antiretroviral therapy persist in a multistate sample of HIV patients in 2001. J Acquir Immune Defic Syndr. 2005;38(1):96–103.
Article
Google Scholar
Des Jarlais DC, Perlis T, Arasteh K, Hagan H, Milliken J, Braine N, et al. “Informed altruism” and “partner restriction” in the reduction of HIV infection in injecting drug users entering detoxification treatment in new York City, 1990–2001. J Acquir Immune Defic Syndr. 2004;35(2):158–66.
Article
Google Scholar
Hall HI, McDavid K, Ling Q, Sloggett A. Determinants of progression to AIDS or death after HIV diagnosis, United States, 1996 to 2001. Ann Epidemiol. 2006;16(11):824–33.
Article
Google Scholar
Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol. 2009;62(10):e1–e34.
Article
Google Scholar
Antinori A, Coenen T, Costagiola D, Dedes N, Ellefson M, Gatell J, et al. Late presentation of HIV infection: a consensus definition. HIV Med. 2011;12(1):61–4.
Article
CAS
Google Scholar
Hu X, Liang B, Zhou C, Jiang J, Huang J, Ning C, et al. HIV late presentation and advanced HIV disease among patients with newly diagnosed HIV/AIDS in southwestern China: a large-scale cross-sectional study. AIDS Res Ther. 2019;16(1):6.
Article
Google Scholar
Wójcik-Cichy K, Jabłonowska O, Piekarska A, Jabłonowska E. The high incidence of late presenters for HIV/AIDS infection in the Lodz province, Poland in the years 2009–2016: we are still far from the UNAIDS 90% target. AIDS Care. 2018;30(12):1538–41.
Article
Google Scholar
Brännström J, Svedhem Johansson V, Marrone G, Wendahl S, Yilmaz A, Blaxhult A, et al. Deficiencies in the health care system contribute to a high rate of late HIV diagnosis in Sweden. HIV Med. 2016;17(6):425–35.
Article
Google Scholar
Wilton J, Light L, Gardner S, Rachlis B, Conway T, Cooper C, et al. Late diagnosis, delayed presentation and late presentation among persons enrolled in a clinical HIV cohort in Ontario, Canada (1999–2013). HIV Med. 2019;20(2):110–20.
Article
CAS
Google Scholar
Camoni L, Raimondo M, Regine V, Salfa MC, Suligoi B. Late presenters among persons with a new HIV diagnosis in Italy, 2010–2011. BMC Public Health. 2013;13(1):281.
Article
Google Scholar
Siwak E, Horban A, Witak-Jędra M, Cielniak I, Firląg-Burkacka E, Leszczyszyn-Pynka M, et al. Long-term trends in HIV care entry: over 15 years of clinical experience from Poland. HIV Med. 2019;20(9):581–90.
Article
CAS
Google Scholar
Sobrino-Vegas P, Pérez-Hoyos S, Geskus R, Padilla B, Segura F, Rubio R, et al. Imputation of the date of HIV seroconversion in a cohort of seroprevalent subjects: implications for analysis of late HIV diagnosis. AIDS Res Treat. 2012;2012:725412.
PubMed
Google Scholar
De Coul ELO, Van Sighem A, Brinkman K, Van Benthem BH, Van Der Ende ME, Geerlings S, et al. Factors associated with presenting late or with advanced HIV disease in the Netherlands, 1996–2014: results from a national observational cohort. BMJ Open. 2016;6(1):e009688.
Article
Google Scholar
Vives N, Carnicer-Pont D, De Olalla PG, Camps N, Esteve A, Casabona J, et al. Factors associated with late presentation of HIV infection in Catalonia, Spain. Int J STD AIDS. 2012;23(7):475–80.
Article
CAS
Google Scholar
Metallidis S, Pilalas D, Skoura L, Haidich AB, Tsachouridou O, Papaioannou M, et al. Time trends and correlates of late presentation for HIV care in northern Greece during the decade 2000 to 2010. J Int AIDS Soc. 2012;15(2):17395.
Article
Google Scholar
Altice FL, Kamarulzaman A, Soriano VV, Schechter M, Friedland GH. Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs. Lancet. 2010;376(9738):367–87.
Article
Google Scholar
Wolfe D, Carrieri MP, Shepard D. Treatment and care for injecting drug users with HIV infection: a review of barriers and ways forward. Lancet. 2010;376(9738):355–66.
Article
Google Scholar
Dukers-Muijrers NH, Niekamp A-M, Vergoossen M, Hoebe C. Effectiveness of an opting-out strategy for HIV testing: evaluation of 4 years of standard HIV testing in a STI clinic. Sex Transm Infect. 2009;85(3):226–30.
Article
CAS
Google Scholar
Götz HM, van Rooijen MS, Vriens P, de Coul EO, Hamers M, Heijman T, et al. Initial evaluation of use of an online partner notification tool for STI, called ‘suggest a test’: a cross sectional pilot study. Sex Transm Infect. 2014;90(3):195–200.
Article
Google Scholar
van Aar F, van Weert Y, Spijker R, Götz H, Op de Coul E, Group PN. Partner notification among men who have sex with men and heterosexuals with STI/HIV: different outcomes and challenges. Int J STD AIDS. 2015;26(8):565–73.
Article
Google Scholar
Grigoryan A, Hall HI, Durant T, Wei X. Late HIV diagnosis and determinants of progression to AIDS or death after HIV diagnosis among injection drug users, 33 US states, 1996–2004. PLoS One. 2009;4(2):e4445.
Article
Google Scholar
Ianache I, Calistru P, Tardei G, Ruta S, Oprea C. Late presentation in HIV-infected injecting drug users-a huge challenge for the Romanian health-care system. Roman J Legal Med. 2016;24(2):122–7.
Google Scholar
Jiang H, Yin J, Fan Y, Liu J, Zhang Z, Liu L, et al. Gender difference in advanced HIV disease and late presentation according to European consensus definitions. Sci Rep. 2015;5:14543.
Article
CAS
Google Scholar
Noble G, Okpo E, Tonna I, Fielding S. Factors associated with late HIV diagnosis in north-East Scotland: a six-year retrospective study. Public Health. 2016;139:36–43.
Article
CAS
Google Scholar
Yombi JC, Jonckheere S, Vincent A, Wilmes D, Vandercam B, Belkhir L. Late presentation for human immunodeficiency virus HIV diagnosis results of a Belgian single Centre. Acta Clin Belg. 2014;69(1):33–9.
Article
CAS
Google Scholar
Drain PK, Losina E, Parker G, Giddy J, Ross D, Katz JN, et al. Risk factors for late-stage HIV disease presentation at initial HIV diagnosis in Durban, South Africa. PLoS One. 2013;8(1):e55305.
Article
CAS
Google Scholar
Hu DJ, Byers R, Fleming PL, Ward JW. Characteristics of persons with late AIDS diagnosis in the United States. Am J Prev Med. 1995;11(2):114–9.
Article
CAS
Google Scholar
Tramarin A, Campostrini S, Tolley K, De Lalla F. The influence of socioeconomic status on health service utilisation by patients with AIDS in North Italy. Soc Sci Med. 1997;45(6):859–66.
Article
CAS
Google Scholar
Carrieri M, Moatti J, Vlahov D, Obadia Y, Reynaud-Maurupt C, Chesney M, et al. Access to antiretroviral treatment among French HIV infected injection drug users: the influence of continued drug use. J Epidemiol Community Health. 1999;53(1):4–8.
Article
CAS
Google Scholar
Girardi E, Aloisi MS, Arici C, Pezzotti P, Serraino D, Balzano R, et al. Delayed presentation and late testing for HIV: demographic and behavioral risk factors in a multicenter study in Italy. J Acquir Immune Defic Syndr. 2004;36(4):951–9.
Article
Google Scholar